Charles Burdet
Délégation Paris 5(FR)Inserm(FR)Inserm(FR)Université Paris Cité(FR)Sorbonne Université(FR)Université Sorbonne Paris Nord(FR)Sorbonne Paris Cité(FR)Assistance Publique – Hôpitaux de Paris(FR)Hôpital Bichat-Claude-Bernard(FR)Centre d'Investigation Clinique Bichat
Publications by Year
Research Areas
SARS-CoV-2 and COVID-19 Research, COVID-19 Clinical Research Studies, Gut microbiota and health, Clostridium difficile and Clostridium perfringens research, Antibiotic Resistance in Bacteria
Most-Cited Works
- → Trends in Human Fecal Carriage of Extended-Spectrum β-Lactamases in the Community: Toward the Globalization of CTX-M(2013)656 cited
- → X-linked recessive TLR7 deficiency in ~1% of men under 60 years old with life-threatening COVID-19(2021)415 cited
- → Remdesivir plus standard of care versus standard of care alone for the treatment of patients admitted to hospital with COVID-19 (DisCoVeRy): a phase 3, randomised, controlled, open-label trial(2021)340 cited
- → Protection of the Human Gut Microbiome From Antibiotics(2017)161 cited
- → Viral-bacterial coinfection affects the presentation and alters the prognosis of severe community-acquired pneumonia(2016)157 cited
- → Discontinuing β-lactam treatment after 3 days for patients with community-acquired pneumonia in non-critical care wards (PTC): a double-blind, randomised, placebo-controlled, non-inferiority trial